Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The study of synergistic inhibition of tumor cell proliferation by CK2 casein kinase inhibitors and inhibitors of thymidylate synthase

2014/13/B/NZ7/02273

Keywords:

casein kinase CK2 thymidylate synthase anticancer agents

Descriptors:

  • NZ7_16: Other related subjects

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Politechnika Warszawska, Wydział Chemiczny

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Maria Bretner 

Number of co-investigators in the project: 10

Call: OPUS 7 - announced on 2014-03-17

Amount awarded: 1 093 450 PLN

Project start date (Y-m-d): 2015-02-02

Project end date (Y-m-d): 2019-02-01

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Equipment purchased [PL]

  1. inkubator z wytrząsaniem (40 000 PLN)
  2. Termocykler gradientowy (32 000 PLN)
  3. komora laminarna.
  4. komputer z drukarką i oprogramowaniem (2 szt.) (6 000 PLN)
  5. spektrofotometr UV/VIS z oprogramowaniem i przystawką do badania kinetyki (65 000 PLN)
  6. zamrażarka głębokiego mrożenia (-86oC) (45 000 PLN)

Information in the final report

  • Publication in academic press/journals (7)
  1. Human dihydrofolate reductase is a substrate of protein kinase CK2α
    Authors:
    Katarzyna Skierka; Paweł Wilamowski; Monika Wielechowska; Dominik Cysewski, Elżbieta Senkara; Patrycja Wińska; Maria Bretner; Joanna Cieśla
    Academic press:
    Biochemical and Biophysical Research Communications (rok: 2019, tom: 513, strony: 368-373), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bbrc.2019.03.186 - link to the publication
  2. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
    Authors:
    Wińska P, Skierka K, Łukowska-Chojnacka E, Koronkiewicz M, Cieśla J, Bretner M.
    Academic press:
    Anticancer Reserch (rok: 2018, tom: 38, strony: 4617-4627), Wydawca: International Institute of Anticancer Research
    Status:
    Published
    DOI:
    10.21873/anticanres.12766 - link to the publication
  3. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives
    Authors:
    Konrad Chojnacki, Patrycja Winska, Katarzyna Skierka, Monika Wielechowska, Maria Bretner
    Academic press:
    Bioorganic Chemistry (rok: 2017, tom: 72, strony: 45301), Wydawca: elsevier
    Status:
    Published
  4. Study of the physicochemical properties of protein kinase CK2 inhibitors -TBBt, TBBi and 2-Me-TBBi
    Authors:
    Edyta Łukowska-Chojnacka, Aneta Pobudkowska, Maria Bretner
    Academic press:
    Fluid Phase Equilibria (rok: 2019, tom: 479, strony: 52-62), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.fluid.2018.09.015 - link to the publication
  5. Synthesis of novel proxyphylline derivatives with dual Anti-Candida albicans and anticancer activity
    Authors:
    Paweł Borowiecki, Patrycja Winska, Maria Bretner, Małgorzata Gizinska, Mirosława Koronkiewicz, Monika Staniszewska
    Academic press:
    European Journal of Medicinal Chemistry (rok: 2018, tom: 150, strony: 307-333), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2018.02.077 - link to the publication
  6. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases
    Authors:
    K. Chojnacki, P. Wińska, M. Wielechowska, E. Łukowska-Chojnacka, C. Tölzer, K. Niefind, M. Bretner
    Academic press:
    Bioorganic Chemistry (rok: 2018, tom: 80, strony: 266-275), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bioorg.2018.06.022 - link to the publication
  7. Simultaneous inhibition of protein kinase CK2 and dihydrofolate reductase results in synergistic effect in acute lymphoblastic leukemia
    Authors:
    Patrycja Wińska, Łukasz Widło, Katarzyna Skierka, Alicja Krzyśko, Mirosława Koronkiewicz, Jarosław Cieśla, Joanna Cieśla, Maria Bretner
    Academic press:
    Anticancer Research (rok: 2019, tom: 39, strony: 3531-3542), Wydawca: Anticancer research
    Status:
    Published
    DOI:
    10.21873/anticanres.13499 - link to the publication